Hennes, E. Et Al. 2017. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. NEUROLOGY , vol.89, no.9 , 900-908.

Hennes, E., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., ... Brantner-Inthaler, S.(2017). Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. NEUROLOGY , vol.89, no.9, 900-908.

Hennes, Eva-Maria Et Al. "Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome," NEUROLOGY , vol.89, no.9, 900-908, 2017

Hennes, Eva-Maria Et Al. "Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome." NEUROLOGY , vol.89, no.9, pp.900-908, 2017

Hennes, E. Et Al. (2017) . "Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome." NEUROLOGY , vol.89, no.9, pp.900-908.

@article{article, author={Eva-Maria Hennes Et Al. }, title={Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome}, journal={NEUROLOGY}, year=2017, pages={900-908} }